A novel predictor for the use of concurrent chemotherapy in early-stage cervical cancer with intermediate-risk factors

OBJECTIVE: For early-stage cervical cancer patients experiencing radical surgery, postoperative radiotherapy was recommended for patients with a combination of intermediate-risk factors. However, there was no consensus on whether to administer concurrent chemotherapy. The aim of the study was to con...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chunli, Wang, Cong, Qian, Qiuhong, Zhang, Youzhong, Ma, Changdong, Miao, Li, Zhang, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300080/
https://www.ncbi.nlm.nih.gov/pubmed/37389134
http://dx.doi.org/10.1016/j.gore.2023.101228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300080/
https://www.ncbi.nlm.nih.gov/pubmed/37389134
http://dx.doi.org/10.1016/j.gore.2023.101228

Ejemplares similares